Control of Taenia solium taeniasis/cysticercosis: past practices and new possibilities

SUMMARY Neurocysticercosis continues to be a major health burden on humans living in many regions of the world, despite the availability of highly effective taeniacides and identification of the cause, Taenia solium, as being potentially eradicable. Several T. solium control trials have been undertaken, generally achieving limited success and none that has been fully documented has achieved what was demonstrated to be a sustainable level of disease control. Pigs act as intermediate hosts for T. solium and two new control tools have become available for application in pigs – single-dose oxfendazole treatment of porcine cysticercosis and the TSOL18 vaccine. Three potential intervention scenarios for pigs are compared for control of cysticercosis, using either oxfendazole or vaccination. A control scenario involving vaccination plus oxfendazole treatment delivered at 4 monthly intervals was predicted to achieve the best outcome, with no pigs slaughtered at 12 months of age having viable T. solium cysticerci. Now that new control tools are available, there are opportunities to concentrate research attention on evaluation of novel control scenarios leading to the implementation of effective and sustainable control programmes and a reduction in the global burden of neurocysticercosis.

[1]  C. Sikasunge,et al.  Efficacy and Safety of Anthelmintics Tested against Taenia solium Cysticercosis in Pigs , 2013, PLoS neglected tropical diseases.

[2]  C. Lanusse,et al.  Efficacy of a single high oxfendazole dose against gastrointestinal nematodes in naturally infected pigs. , 2013, Veterinary parasitology.

[3]  R. Gilman,et al.  Relationship between Serum Antibodies and Taenia solium Larvae Burden in Pigs Raised in Field Conditions , 2013, PLoS neglected tropical diseases.

[4]  N. Speybroeck,et al.  Complexities in using sentinel pigs to study Taenia solium transmission dynamics under field conditions. , 2013, Veterinary parasitology.

[5]  A. Flisser.  Epidemiology of Neurocysticercosis in Mexico: From a Public Health Problem to Its Control , 2013 .

[6]  C. Sikasunge,et al.  The effect of oxfendazole treatment on muscle pathology in pigs infected with Taenia solium cysticercosis. , 2012, Veterinary parasitology.

[7]  C. Lanusse,et al.  A high oxfendazole dose to control porcine cysticercosis: pharmacokinetics and tissue residue profiles. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[8]  C. Jayashi,et al.  Successful immunization of naturally reared pigs against porcine cysticercosis with a recombinant oncosphere antigen vaccine , 2012, Veterinary parasitology.

[9]  R. Gilman,et al.  Prevention and control of Taenia solium taeniasis/cysticercosis in Peru , 2012, Pathogens and global health.

[10]  Armando E Gonzalez,et al.  Protection of pigs against Taenia solium cysticercosis by immunization with novel recombinant antigens , 2012, Vaccine.

[11]  L. Neves,et al.  Use of Oxfendazole to Control Porcine Cysticercosis in a High-Endemic Area of Mozambique , 2012, PLoS neglected tropical diseases.

[12]  O. H. Brutto,et al.  Changing pattern of neurocysticercosis in an urban endemic center (Guayaquil, Ecuador) , 2012, Journal of Neurological Sciences.

[13]  Héctor H. Garcia,et al.  Epidemiología y control de la cisticercosis en el Perú , 2010 .

[14]  A. Flisser,et al.  Neurocysticercosis May No Longer Be a Public Health Problem in Mexico , 2010, PLoS neglected tropical diseases.

[15]  M. Lightowlers.  Fact or hypothesis: Taenia crassiceps as a model for Taenia solium, and the S3Pvac vaccine , 2010, Parasite immunology.

[16]  R. Gilman,et al.  Variation in the cellular localization of host‐protective oncospheral antigens in Taenia saginata and Taenia solium , 2010, Parasite immunology.

[17]  G. Anderson,et al.  Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon , 2010, International journal for parasitology.

[18]  M. Lightowlers.  Eradication of Taenia solium cysticercosis: a role for vaccination of pigs. , 2010, International journal for parasitology.

[19]  Y. Zhang,et al.  The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002–2008 , 2009, Parasitology.

[20]  H. Carabin,et al.  Implementation and evaluation of a health-promotion strategy for control of Taenia solium infections in northern Tanzania , 2009 .

[21]  I. Phiri,et al.  Taenia solium porcine cysticercosis: viability of cysticerci and persistency of antibodies and cysticercal antigens after treatment with oxfendazole. , 2008, Veterinary parasitology.

[22]  H. Carabin,et al.  A health-education intervention trial to reduce porcine cysticercosis in Mbulu District, Tanzania. , 2008, Preventive veterinary medicine.

[23]  G. Fragoso,et al.  Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis. , 2008, Vaccine.

[24]  M. Lightowlers.  Cestode vaccines: origins, current status and future prospects , 2006, Parasitology.

[25]  G. Fragoso,et al.  Further evaluation of the synthetic peptide vaccine S3Pvac against Taenia solium cysticercosis in pigs in an endemic town of Mexico , 2006, Parasitology.

[26]  R. Gilman,et al.  Taenia solium and Taenia ovis: stage-specific expression of the vaccine antigen genes, TSOL18, TSOL16, and homologues, in oncospheres. , 2006, Experimental parasitology.

[27]  L. Moulton,et al.  Combined human and porcine mass chemotherapy for the control of T. solium. , 2006, The American journal of tropical medicine and hygiene.

[28]  A. L. Willingham,et al.  Control of Taenia solium cysticercosis/taeniosis. , 2006, Advances in parasitology.

[29]  Z. Pawłowski,et al.  Control of Taenia solium taeniasis/cysticercosis: from research towards implementation. , 2005, International journal for parasitology.

[30]  H. H. García,et al.  Neurocysticercosis: updated concepts about an old disease , 2005, The Lancet Neurology.

[31]  G. Fragoso,et al.  Therapeutic capacity of the synthetic peptide-based vaccine against Taenia solium cysticercosis in pigs. , 2005, Vaccine.

[32]  R. Gilman,et al.  Vaccination of pigs to control human neurocysticercosis. , 2005, The American journal of tropical medicine and hygiene.

[33]  A. Flisser,et al.  Induction of Protection against Porcine Cysticercosis by Vaccination with Recombinant Oncosphere Antigens , 2004, Infection and Immunity.

[34]  J. Brandt,et al.  Immunodiagnostic approaches for detecting Taenia solium. , 2004, Trends in parasitology.

[35]  N. Speybroeck,et al.  A Bayesian approach for estimating values for prevalence and diagnostic test characteristics of porcine cysticercosis. , 2004, International journal for parasitology.

[36]  J. Brandt,et al.  Experimental infection of pigs with aTaenia species from Korea: parasitological and serological aspects , 2004, Parasitology Research.

[37]  C. Evans,et al.  Taenia solium cysticercosis. , 2000, Lancet.

[38]  P. Schantz.  Taenia solium cysticercosis: an overview of global distribution and transmission. , 2002 .

[39]  E. Sarti.  Epidemiology of Taenia solium taeniasis and cysticercosis in Mexico. , 2002 .

[40]  G. Fragoso,et al.  Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico. , 2001, Vaccine.

[41]  R. Gilman,et al.  Protection of pigs with cysticercosis from further infections after treatment with oxfendazole. , 2001, The American journal of tropical medicine and hygiene.

[42]  R. Medina‐Santillán,et al.  Mass treatment against human taeniasis for the control of cysticercosis: a population-based intervention study. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[43]  R. Gilman,et al.  Persistence of passively transferred antibodies in porcine Taenia solium cysticercosiss , 1999 .

[44]  R. Gilman,et al.  Persistence of passively transferred antibodies in porcine Taenia solium cysticercosis. Cysticercosis Working Group in Peru. , 1999, Veterinary parasitology.

[45]  R. Gilman,et al.  Time-response curve of oxfendazole in the treatment of swine cysticercosis. , 1998, The American journal of tropical medicine and hygiene.

[46]  A. Aluja,et al.  Taenia solium cysticercosis in young pigs: age at first infection and histological characteristics. , 1998, Veterinary parasitology.

[47]  R. Gilman,et al.  Treatment of porcine cysticercosis with oxfendazole: a dose-response trial , 1997, Veterinary Record.

[48]  A. Rivera,et al.  Mass chemotherapy for intestinal Taenia solium infection: effect on prevalence in humans and pigs. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[49]  S. Solano,et al.  Field trial for reducing porcine Taenia solium cysticercosis in Mexico by systematic vaccination of pigs. , 1997, Veterinary parasitology.

[50]  A. Flisser,et al.  Development and evaluation of a health education intervention against Taenia solium in a rural community in Mexico. , 1997, The American journal of tropical medicine and hygiene.

[51]  R. Gilman,et al.  Effective, single-dose treatment or porcine cysticercosis with oxfendazole. , 1996, The American journal of tropical medicine and hygiene.

[52]  G. Fragoso,et al.  Cysticercosis: identification and cloning of protective recombinant antigens. , 1996, The Journal of parasitology.

[53]  P. Tato,et al.  Immunization against porcine cysticercosis in an endemic area in Mexico: a field and laboratory study. , 1993, The American journal of tropical medicine and hygiene.

[54]  M. Cruz,et al.  Potential eradicability of taeniasis and cysticercosis. , 1993, Bulletin of the Pan American Health Organization.

[55]  Update: International Task Force for Disease Eradication. 1992. , 1993, Releve epidemiologique hebdomadaire.

[56]  A. Flisser,et al.  Neurocysticercosis in an Orthodox Jewish community in New York City. , 1992, The New England journal of medicine.

[57]  K. Willms,et al.  Epidemiologic study and control of Taenia solium infections with praziquantel in a rural village of Mexico. , 1991, The American journal of tropical medicine and hygiene.

[58]  R. Gilman,et al.  Efficacy of the immunoblot assay for cysticercosis in pigs and modulated expression of distinct IgM/IgG activities to Taenia solium antigens in experimental infections. , 1991, Veterinary immunology and immunopathology.

[59]  M. Cruz,et al.  Operational studies on the control of Taenia solium taeniasis/cysticercosis in Ecuador. , 1989, Bulletin of the World Health Organization.

[60]  N. Keilbach,et al.  A programme to control taeniasis-cysticercosis (T. solium): experiences in a Mexican village. , 1989, Acta Leidensia.

[61]  A. Flisser,et al.  Taenia solium taeniasis and cysticercosis in a Mexican village. , 1988, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.

[62]  M. Gemmell,et al.  Hydatidosis and cysticercosis: the dynamics of transmission. , 1983, Advances in parasitology.

[63]  J. Arundel.  A review of cysticercoses of sheep and cattle in Australia. , 1972, Australian veterinary journal.

[64]  K. Yoshino.  On the subjective symptoms caused by the parasitism of Taenia solium and its development in man. , 1934 .

[65]  K. Yoshino.  Studies on the Postembryonal Development of Taenia solium. Part III. On the Development of Cysticercus cellulosae within the Definite Intermediate Host. , 1933 .

[66]  K. Yoshino.  Studies on the Postembryonal Development of Taenia solium. Part II. On the Youngest Form of Cysticercus cellulosae and on the Migratory Course of the Oncosphaera of Taenia solium within the Intermediate Host. , 1933 .